Seeking Alpha

Acorda Therapeutics (ACOR): Q3 EPS of $0.38 beats by $0.14. Revenue of $77.4M (-16.8% Y/Y) beats...

Acorda Therapeutics (ACOR): Q3 EPS of $0.38 beats by $0.14. Revenue of $77.4M (-16.8% Y/Y) beats by $2.2M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)